Brief: Plus Therapeutics Received Letter From Nasdaq on March 8 Notifying Co That It No Longer Complies With Requirement Under Nasdaq Listing Rule 5550(B)(1)
14/03/2024 21:14
March 14 (Reuters) - Plus Therapeutics Inc PSTV.O :
* PLUS THERAPEUTICS INC-ON MARCH 8 GOT LETTER FROM NASDAQ
NOTIFYING CO THAT IT NO LONGER COMPLIES WITH REQUIREMENT UNDER
NASDAQ LISTING RULE 5550(B)(1)
Source text for Eikon: ID:n0001193125-24-068002
Further company coverage: PSTV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cerenome
See all newsBrief: Cerenome Secures In-Network Agreement With Florida Blue For Cnside® Csf Tumor Cell Enumeration And Molecular Profile Tests
Plus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Cerenome Secures In-Network Agreement With Health Care Service Corporation
Plus Therapeutics Inc expected to post a loss of 91 cents a share - Earnings Preview
Brief: Plus Therapeutics Secures Regional Coverage Agreement With Medical Mutual For CNSide Cerebrospinal Fluid Assay For Metastatic CNS Cancer